{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:02:13Z","timestamp":1792245733363,"version":"4.4.0"},"reference-count":38,"publisher":"Cambridge University Press (CUP)","issue":"16","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S003329172300212X_sec_a1\"><jats:title>Background<\/jats:title><jats:p>Despite unclear evidence to support the long-term use of antipsychotics to treat challenging (problem) behaviours in people with autism in the absence of a psychiatric disorder, this practice is common.<\/jats:p><\/jats:sec><jats:sec id=\"S003329172300212X_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>We conducted a systematic review and meta-analysis of all randomised controlled trials (RCTs) involving antipsychotics for people with autism of all ages, irrespective of the outcomes assessed. We searched seven databases and hand-searched ten relevant journals. Two authors independently screened titles, abstracts and full papers and extracted data using the Cochrane Handbook template. We conducted meta-analyses of outcomes and the rate of adverse events.<\/jats:p><\/jats:sec><jats:sec id=\"S003329172300212X_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>We included 39 papers based on 21 primary RCTs that recruited 1482 people with autism. No RCT assessed any psychiatric disorder outcome, such as psychoses or bipolar disorder. A meta-analysis of ten placebo-controlled RCTs showed a significantly improved Aberrant Behaviour Checklist-Irritability score in the antipsychotic group with an effect size of \u22126.45 [95% confidence interval (CI) \u22128.13 to \u22124.77] (low certainty). Pooled Clinical Global Impression data on 11 placebo-controlled RCTs showed an overall effect size of 0.84 (95% CI 0.48 to 1.21) (moderate certainty). There was a significantly higher risk of overall adverse effects (<jats:italic>p<\/jats:italic> = 0.003) and also weight gain (<jats:italic>p<\/jats:italic> &lt; 0.00001), sedation (<jats:italic>p<\/jats:italic> &lt; 0.00001) and increased appetite (<jats:italic>p<\/jats:italic> = 0.001) in the antipsychotic group.<\/jats:p><\/jats:sec><jats:sec id=\"S003329172300212X_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>There is some evidence for risperidone and preliminary evidence for aripiprazole to significantly improve scores on some outcome measures among children with autism but not adults or for any other antipsychotics. There is a definite increased risk of antipsychotic-related different adverse effects.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s003329172300212x","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:00:29Z","timestamp":1691136029000},"page":"7964-7972","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":31,"title":["Randomised controlled trials of antipsychotics for people with autism spectrum disorder: a systematic review and a meta-analysis"],"prefix":"10.1017","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-8103","authenticated-orcid":false,"given":"Shoumitro","family":"Deb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharati","family":"Limbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma","family":"Akrout Brizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Santambrogio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"S003329172300212X_ref29","first-page":"839","article-title":"CGI Clinical global impression scale-NIMH","volume":"21","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"key":"S003329172300212X_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2014.05.018"},{"key":"S003329172300212X_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2013.05.028"},{"key":"S003329172300212X_ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"S003329172300212X_ref8","first-page":"1","article-title":"Impact of antipsychotics in children and adolescents with autism spectrum disorder: A systematic review and meta-analysis","volume":"19","author":"D'Al\u00f2","year":"2021","journal-title":"Health Quality and Life Outcomes"},{"key":"S003329172300212X_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2011.07.031"},{"key":"S003329172300212X_ref23","doi-asserted-by":"publisher","DOI":"10.1177\/13623613221117931"},{"key":"S003329172300212X_ref34","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-0264-F"},{"key":"S003329172300212X_ref37","unstructured":"World Health Organization. (2019). International classification of diseases for mortality and morbidity statistics (11th Revision). Retrieved 11 March 2021, from https:\/\/icd.who.int\/browse11\/l-m\/en."},{"key":"S003329172300212X_ref18","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020)","author":"Higgins","year":"2020"},{"key":"S003329172300212X_ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-019-00333-x"},{"key":"S003329172300212X_ref14","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2018.0115"},{"key":"S003329172300212X_ref2","first-page":"283","article-title":"The aberrant behaviour checklist community: Factor validity and effect of subject variables for adults in group homes","volume":"100","author":"Aman","year":"1995","journal-title":"American Journal of Mental Retardation"},{"key":"S003329172300212X_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2020.03.007"},{"key":"S003329172300212X_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.01.012"},{"key":"S003329172300212X_ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199706000-00023"},{"key":"S003329172300212X_ref19","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12644"},{"key":"S003329172300212X_ref6","doi-asserted-by":"publisher","DOI":"10.1108\/AMHID-05-2015-0024"},{"key":"S003329172300212X_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2013.12.004"},{"key":"S003329172300212X_ref20","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604.ch4"},{"key":"S003329172300212X_ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171"},{"key":"S003329172300212X_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/BF02211841"},{"key":"S003329172300212X_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpsy.2021.10.002"},{"key":"S003329172300212X_ref3","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"S003329172300212X_ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008"},{"key":"S003329172300212X_ref28","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"S003329172300212X_ref30","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3782"},{"key":"S003329172300212X_ref7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0900D"},{"key":"S003329172300212X_ref12","first-page":"1","article-title":"Psychopharmacological treatments for psychopathology in people with intellectual disabilities and\/or autism spectrum disorder","author":"Deb","year":"2022","journal-title":"British Journal of Psychiatry Advances"},{"key":"S003329172300212X_ref25","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172145"},{"key":"S003329172300212X_ref22","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2022.18"},{"key":"S003329172300212X_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2016.03.012"},{"key":"S003329172300212X_ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.1003"},{"key":"S003329172300212X_ref5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-95720-3_16"},{"key":"S003329172300212X_ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-12-11"},{"key":"S003329172300212X_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.08.001"},{"key":"S003329172300212X_ref21","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019)","author":"Li","year":"2019"},{"key":"S003329172300212X_ref26","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7011a1externalicon"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S003329172300212X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T01:51:39Z","timestamp":1714960299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S003329172300212X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":38,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S003329172300212X"],"URL":"https:\/\/doi.org\/10.1017\/s003329172300212x","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2023. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}